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บทคดัยอ่ 
วตัถปุระสงค:์ เพื่อประเมนิการน าแผนผงัการใช้ยาเมด็คุมก าเนิดมาใช้ในรา้นยา
ในดา้น 1) การใหค้ าแนะน าปรกึษาตามแผนผงัการใช้ยาเมด็คุมก าเนิด 2) ความ
คดิเห็นของเภสชักรต่อการใช้แผนผงัการใช้ยาเม็ดคุมก าเนิด และ 3) ความพงึ
พอใจของผู้รบับริการต่อการได้รบัค าแนะน าปรึกษาตามแผนผงัการใช้ยาเม็ด
คุมก าเนิด วิธีการศึกษา: การศกึษาเชงิพรรณนาภาคตดัขวาง กลุ่มตวัอย่างเป็น
เภสัชก รผู้มีห น้ าที่ปฏิบัติก า ร ในร้ านยาแผน ปัจจุ บัน  เ ขตภาษี เ จ ริญ 
กรุงเทพมหานคร จ านวน 13 คน (รา้นละ 1 คน) และผูร้บับรกิาร จ านวน 390 คน 
(รา้นละ 30 คน) เครื่องมอืวจิยัเป็นแบบสอบถามของเภสชักร แบบบนัทกึขอ้มูล
ผูร้บับรกิาร แบบสมัภาษณ์แบบมโีครงสรา้ง และแบบสอบถามความพงึพอใจของ
ผูร้บับรกิาร เก็บรวบรวมขอ้มูลระหว่างวนัที่ 23 พฤศจกิายน พ.ศ. 2559 ถึง 23 
มกราคม พ.ศ. 2560 วเิคราะห์ข้อมูลโดยใช้สถิตเิชิงพรรณนา ผลการศึกษา: 
เภสชักรใหค้ าแนะน าปรกึษาเรือ่งยาเมด็คุมก าเนิดแก่ผูร้บับรกิารจ านวน 390 คน 
รวมทัง้หมด 580 เรือ่ง สว่นใหญ่ใหค้ าแนะน าปรกึษาคนละ 1 เรือ่ง (รอ้ยละ 71.79) 
เรื่องทีใ่หค้ าแนะน าปรกึษามากทีสุ่ดคอื การแก้ไขอาการไมพ่งึประสงคจ์ากการใช้
ยาเมด็คุมก าเนิดคดิเป็นรอ้ยละ 31.00 (180 เรื่อง) เภสชักรทุกคนเหน็ว่าการน า
แผนผงัการใช้ยาเม็ดคุมก าเนิดมาใช้ในรา้นยาสามารถช่วยเภสชักรให้ค าแนะน า
ปรกึษาเรือ่งยาเมด็คุมก าเนิดอย่างมปีระสทิธภิาพมากขึ้น แตห่ากมกีารน าแผนผงั
การใช้ยาเม็ดคุมก าเนิดมาใช้ในการปฏิบตังิานจรงิควรแก้ไขปรบัปรุงแผนผงัใน
เรื่องของลกัษณะทัว่ไปและเนื้อหาของแผนผงัการใช้ยาเม็ดคุมก าเนิดเพื่อให้
เหมาะสมกบับรบิทของรา้นยามากขึน้ ส่วนผูร้บับรกิารมคีวามพงึพอใจโดยรวมต่อ
การได้รบัค าแนะน าปรกึษาตามแผนผงัการใช้ยาเม็ดคุมก าเนิดอยู่ในระดบัมาก
ทีสุ่ด (คา่เฉลีย่ 4.53 จากคะแนนเตม็ 5 คะแนน) สรปุ: การน าแผนผงัการใชย้าเมด็
คุมก าเนิดมาใชใ้นรา้นยามปีระโยชน์ต่อเภสชักรและผูร้บับรกิาร และผูร้บับรกิารมี
ความพงึพอใจโดยรวมตอ่ค าแนะน าปรกึษาตามแผนผงัการใช้ยาเมด็คุมก าเนิดใน
ระดบัมากทีสุ่ด  
ค าส าคญั: การประเมนิ, แผนผงัการใชย้าเมด็คุมก าเนิด, รา้นยา, ความพงึพอใจ  
 
Abstract 
Objectives: To assess the oral contraceptive pill (OCP) flowchart in 
community pharmacy regarding 1) the advices of oral contraceptives 
provided with the use of the OCP flowchart 2) opinion of community 
pharmacists on the OCP flowchart and 3) satisfaction of customers toward 
the advices based on the OCP flowchart. Method: In this cross-sectional 
descriptive study, data were collected from 13 pharmacists working in 13 
community pharmacies in Phasi Charoen, Bangkok and 390 customers (30 
customers from each pharmacy) between 23 November 2016 and 23 
January 2017. The instruments were questionnaires, customer collection 
form and structured interview questionnaire. Descriptive statistics were 
employed. Results: Community pharmacist provided 580 advice topics on 
oral contraceptive use for 390 customers. Majority of the customers received 
one advice (71.79%). The most provided advice topic was the management 
of OCP-related side effects (180 of 580 advices, or 31.00%). All community 
pharmacists agreed that using the OCP flowchart in drugstore could help 
them provide OCP advice more effectively. However, before actual 
implementation, the OCP flowchart needed some improvement including 
general layout and certain content to suit the context of community pharmacy. 
It was found that the customers had the highest satisfaction towards the 
advice based on the OCP flowchart (a mean score of 4.53 of 5 points). 
Conclusion: Oral contraceptive flowchart was useful for the community 
pharmacists and customers. The customer had the highest satisfaction 
toward the advices based on the flowchart.  
Keywords: assessment, oral contraceptive flowchart, community pharmacy, 
drugstore, satisfaction  
Introduction 
With a success in the 1970 national family planning 
program to decelerate the population increase rate, 
contraception has been increasingly and widely used among 
Thais. In 2014, as high as 70% of Thai couples used at least 
one form of contraception.1 Two types of contraception, 
temporary and permanent, have been widely used.2,3 Oral 
contraceptive pill (OCP) has been the most popular temporary 
contraception. A survey in 2009 among 12,792,561 
reproductive women aged 15 – 49 years found that OCPs 
were used in the largest proportion of the women (35.00%). 
They reported that OCPs offered convenience, acceptable 
effectiveness, infrequent, benign and manageable adverse 
effects, and a wide variety of products regarding the price.4  
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Despite various advantages of OCPs, previous literature 
suggested a poor level of the OCP use knowledge. These 
drawbacks included a lack of knowledge in medications 
contraindicated with the OCP (97.40%)5, severe adverse 
events prompting a discontinuation and medical attention 
( 68.45%)6, contraindications (54.20%)7, and poor 
management when missing at least 2 OCP tablets (39.33%).8 
In addition, only 4.50% and 1.60% of the OCP users 
understood the initiation of the 21- and 28-day OCPs, 
respectively.5 On the healthcare provider side, incomplete 
advice on the OCP use was given to the clients. Specifically 
only 77.08% of the clients were given information regarding 
OCP’s adverse events.9  
Drugstore or community pharmacy is the healthcare 
service firstly sought by patients with mild health problems. In 
Thailand, a number of community pharmacy have been 
increasing rapidly. With an increase rate of 26.69% in 2013, a 
total of 15,359 pharmacies were found nation-wide in 2014.10 
As a number of community pharmacy have been growing, a 
diverse practice could be expected. The Thai Pharmacy 
Council has been attempting to establish a standard practice 
for community pharmacies to follow.11 It has been known that 
a large number of community pharmacy have been willing to 
follow this development. However, with a lack of standard 
practice guideline for specific operations and maneuvers, most 
community pharmacies could not deliver complete standard 
services. As suggested by various studies, responsible 
agencies were expected to establish standard practice 
guideline for effective community pharmacy services.12-15  
The recommendation on OCP use is a basic service that 
should be readily available at the community pharmacy.16 In 
Thailand, however, the guideline for recommending the OCP use 
in community pharmacy has not been established. Diverse and 
incomplete recommendations on the OCP use could be inevitable 
and further lead to incorrect use of OCPs. As a result of failed 
contraception, unintentional pregnancies could lead to unsafe 
abortion which is one of the major public health problems of the 
country. There has been an effort to improve the consultation on 
OCP use at community pharmacy using an OCP flowchart.17 To 
facilitate the pharmacist in history taking and recommending the 
use of OCP, the OCP flowchart depicts the crucial topics from 
history taking, to selecting OCP products suitable for individual 
clients, precaution and contraindication in specific clients, how to 
start the OCP, how to manage the schedule in case of missing 
doses or losing the pill from vomiting or diarrhea, adverse effects 
and how to manage them, and switching from other contraceptive 
methods to the OCP. However, this flowchart has not been 
evaluated for its usefulness. To advocate the further use of this 
OCP flowchart, an evidence of its benefit and information 
necessary for improvement were highly needed. Specifically, the 
objectives of this study were to determine 1) frequency of use of 
each topic on the OCP flowchart in providing care to the clients, 
2) opinion of the community pharmacists in using the OCP 
flowchart, and 3) satisfaction of the clients in receiving 
consultation based on the OCP flowchart.  
In this study, oral contraceptive pill (OCP) included those 
products with estrogen and/or progestogen with 21 or 28 oral 
tablets in the package intended for contraception. The OCP 
flowchart was the diagram of OCP use and related information 
created by Kingkarn Wichit, RPh. The flowchart was presented 
as a 14-page flipchart. The flowchart covered crucial topics which 
were placed in order from history taking, to selecting OCP 
products suitable for individual clients, precaution and 
contraindication for specific clients, how to start the OCP, how to 
manage the schedule in case of missing doses or losing the pill 
from vomiting or diarrhea, adverse effects and how to manage 
them, and switching from other contraceptive methods to OCP.17 
The consultation based on the OCP flowchart on various 
topics including how to start in clients who had never used 
OCP, how to replace the pill in case of losing a pill from 
vomiting or diarrhea, how to switch from other contraception 
method to the OCP, what to do if missing a pill, 
contraindication of the estrogen-containing OCPs. In addition, 
the flowchart also prompted the pharmacists to remind the 
clients on the possible adverse effects relevant to specific type 
of OCPs including nausea and vomiting, dizziness, excessive 
vaginal discharge, melasma, migraine headache, breast 
engorgement and/or tenderness, edema, dysmenorrhea or 
cramp, menstrual spotting, amenorrhea, increased appetite, 
weight gain, tiredness/fatigue, acne, oily scalp and face, 
hursuitism, depression, fungal vaginal infection, agitation, 
dysfunctional uterine bleeding, loss of libido, hair loss, and dry 
skin. In this study, we included only pharmacists working full-
time in the independent first class drugstores in the district of 
Phasi Charoen, Bangkok.  
 
Methods 
 
In this cross-sectional descriptive study, we recruited 
participants, both pharmacists and customers, with the 
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purposive sampling method. The pharmacist participants were 
those working full-time in the independent first class 
drugstores in the district of Phasi Charoen, Bangkok. Only one 
pharmacist was selected from each drugstore. With 13 stores 
to study, a total of 13 pharmacists were recruited.18 For 
customer participants, the sample size was estimated based 
on Cochran method.19 The estimation was based on a 95% 
confidence level, a sampling error rate (d) of 5%, with a 
proportion (p) for unknown or infinite size of the population. 
As a result, 390 customers, or 30 per store, were needed. To 
be eligible, these customer participants were women aged 20 
or older, requesting OCPs for contraception for themselves. 
There had to be able to communicate in Thai. Those who had 
been using OCP for 90 days or greater with no OCP-related 
problems were excluded from the study. The study was 
conducted from November 23, 2016, to January 23, 2017.  
 
Instruments  
Data collection tools included four sets of questions. In the 
first set of questions, we asked for demographic information 
of the pharmacist participants, demographic information of the 
drugstores, and the existing OCP use counseling service 
provided to the customers, for example, history taking and 
OCP recommendations. The second set of the questions 
recorded the customer information requested by the 
pharmacist participant. This questionnaire was modified from 
the customer data collection form on providing knowledge, 
recommendation, and consultation on family planning for 
reproductive women and the spouses in the research project 
entitled health promotion in the drugstore in the Bangkok 
metropolitan.20 This form collected demographic information of 
the customer, recommendations on the OCP to the customer, 
and summary of the OCP use counseling for each customer 
according to the OCP flowchart.  
The third set of the questions asked the pharmacist 
participant their opinion on the use of OCP flowchart. With 
open-ended format, the questions asked about the flowchart’s 
general appearance, content, convenience to use, problems 
found in the use, and benefits. Finally, the fourth set of six 
questions asked the customer participants about their 
satisfaction toward the OCP use counseling service. The 
questions asked the customers to rate their satisfaction on the 
readiness of the pharmacist in providing OCP use advice, 
history taking, actual advice on the OCP use, answering the 
customer’s questions, the overall satisfaction on the OCP use, 
and the future use of the OCP use service. The response was 
a rating scale with 1-the least satisfied to 5-the most satisfied. 
The total score was achieved by summing up the score of 
each of the six questions and dividing by 6. This customer’s 
overall satisfaction levels on the OCP use counseling service 
were categorized as the most satisfied (4.51 - 5.00), highly 
satisfied (3.51 - 4.50), moderately satisfied (2.50 - 3.50), 
slightly satisfied (1.51 - 2.50), and the least satisfied (1.00 - 
1.50).21 The questionnaire was tested for content validity by 
three experts.   
  
Data collection procedure  
Data collection form and OCP flowchart were given to 13 
participating drugstores. Pharmacist participants were 
instructed by the researchers to use the flowchart. The 
pharmacists were asked to provide OCP use counseling using 
the flowchart and record the data in the forms at the end of 
the service. They were also asked to ask to customer to fill in 
the customer satisfaction questionnaire (4th questionnaire). 
The researchers contacted the pharmacist participant once a 
week by the actual visit or telephone call to define the 
problems if any, and provide the assistance if necessary. For 
each drugstore, once a total of 30 customers were provided 
the OCP counseling service, the researchers interviewed the 
pharmacist participant using the third questionnaire.  
This study was approved by the Ethics Committee for 
Human Research in Health Science of Naresuan University 
on November 22, 2016 (Issue no. 691/59).  
 
  Statistical Analysis  
Descriptive statistics were presented as frequency with 
percentage, mean with standard deviation, and median with 
inter-quartile range (IQR), when applicable. Data from 
structured interview with the pharmacists on the use of OCP 
flowchart were analyzed with content analysis. Each of the 
findings was grouped and counted. The customer satisfaction 
on the OCP use counseling was presented as frequency and 
percentage of each satisfaction level.    
 
 
Results 
 
The first part was the general and demographic 
information of the participating pharmacists. Most pharmacists 
were female (11 of 13), with an average age of 29 years. All 
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pharmacists finished the bachelor’s degree, with a mean of 4 
years in working in community pharmacy. With an average of 
60 customers per day, there were 8 customers per day by 
average asking for OCP use counseling. Most drugstores had 
one pharmacist on duty on a daily basis with no assistant. 
Before dispensing OCP, 8 of 13 pharmacists asked necessary 
information in the history taking which included verifying the 
OCP user, drug allergy history, and existing illnesses or health 
problems. All pharmacists provided OCP use counseling with 
no educational materials for assistance. Six of them had no 
guideline for follow-up and four pharmacists provided 
educational leaflet of OCP use. Five minutes per customer by 
average were used in the OCP use counseling. (Table 1).  
 
 
 Table 1  Characteristics of the pharmacist and drugstore 
participants and the OCP use consultation service (N = 13).   
Characteristics  N (%) 
Pharmacist participants   
Gender  
Female 11 (84.61)  
Male 2 (15.39)  
Age (yrs), median ± IQR = 29 ± 5.25; range 25 - 53  
Education level   
Bachelor’s degree 13 (100.00)  
Experience in community pharmacy (yrs), median ± IQR = 4.0 ± 4.0; range 0.5 – 30.0   
Drugstores   
Number of customers per day, median ± IQR = 60.0 ± 25.0; range 30 – 200  
Number of customers requesting OCP product and/or consultation per day, median ± IQR = 
8.0 ± 2.75; range 3 – 21  
Number of pharmacists on duty per day   
1                                                                                                                                                                             11 (84.61)
2                                                                                                               2 (15.39)  
Number of pharmacy assistants  
0                                                                                  9 (69.23) 
1                                                                                                           3 (23.08) 
2                                                                                                               1 (7.69) 
OCP use consultation service     
History taking and/or drug-related problems (DRP) before OCP 
dispensary  
 
No history taking or DRP verification  0  
Limited history taking  8 (61.54)  
Thorough history taking  5 (38.46)  
Protocol/guideline on OCP use consultation (more than 1 mode was applicable)  
No protocol/guideline  0  
Verbal consultation with no written educational material used 13 (100.00)   
Written educational materials used  0   
 (contd.) 
 
 
 
 
 
 
 
 
 
 
Table 1  Characteristics of the pharmacist and drugstore 
participants and the OCP use consultation service (N = 13) (Contd.).   
Characteristics  N (%) 
Protocol/guideline on monitoring OCP use   
No protocol/guideline  6 (46.15)  
Making an appointment (phone call or in-store) for all customers  0  
Making an appointment  (phone call or in-store) only for customers with the 
first OCP use  
1 (7.69)  
Making an appointment  (phone call or in-store) only for customers with OCP 
related problems 
3 (23.08)  
Making an in-store appointment only for customers with the first OCP use or 
with OCP-related problems  
3 (23.08)  
Making a telephone call appointment only for customers with the first OCP 
use 
0  
Making a telephone call appointment only for customers with the OCP-related 
problems  
0  
Availability of educational materials on the OCP use   
No  9 (69.23)  
Yes (leaflets)  4 (30.77)  
Number of minutes of OCP use consultation service, median ± QD = 5 ± 2.50; range 5 – 
10 
  
 
Of the 390 customers, the majority were 30 years old, with 
high-school diploma or equivalent (44.10%), private sector 
employees (52.82%), with a monthly income of 15,001 - 
20,000 baht (37.89%), having no existing illnesses or health 
problems (92.80%), using no medications (95.89%), having no 
allergies to medications, food, herbs or nutritional supplements 
(98.20%), not smoking (99.49%), and having no child (71.54%) 
(Table 2).    
 
 Table 2  Characteristics of the customers (N = 390).  
Characteristics N  % 
Age (yrs), median ± IQR = 30 ± 6; range 20 - 57                                                                              
Education level   
Elementary school 22 5.64 
Middle school 38 9.70 
High school or equivalent  172 44.10 
Bachelor’s degree or equivalent 157 40.30 
Post-graduate degree 1 0.26 
Occupation   
Business employee 206 52.82 
Labor  76 19.49 
Small business owner  70 17.95 
Government employee  22 5.64 
Shopkeeper  4 1.03 
Unemployed  12 3.07 
Monthly income (Baht) (n = 388)   
 10,000  53 13.66 
10,001 - 15,000 108 27.84 
15,001 - 20,000 147 37.89 
20,001 - 25,000 35 9.02 
25,001 - 30,000 36 9.28 
 30,000  9 2.31 
  (Contd.) 
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 Table 2  Characteristics of the customers (N = 390) (Contd.).  
Characteristics N  % 
Underlying disease   
No   362 92.80 
Yes  28 7.20 
Hypertension 9 32.15 
Migraine without aura 4 14.28 
Hypothyroidism 3 10.72 
Hyperthyroidism 3 10.72 
Asthma 2 7.14 
Dyslipidemia 1 3.57 
Diabetes mellitus 1 3.57 
Allergic rhinitis 1 3.57 
Peptic ulcer 1 3.57 
Hypertension and dyslipidemia 2 7.14 
Hypertension and arrhythmia 1 3.57 
Medication   
No  374 95.89 
Yes 16 4.11 
Amlodipine 2 12.50 
Levothyroxine 2 12.50 
Atenolol 1 6.25 
Enalapril 1 6.25 
Propylthiouracil 1 6.25 
Methimazole 1 6.25 
Theophylline 1 6.25 
Cetirizine 1 6.25 
Metformin and glipizide 1 6.25 
Amlodipine, atenolol และ simvastatin 2 12.50 
Others  3 18.75 
Allergy to drugs/food/herbs/other products   
No   383 98.20 
Yes  7 1.80 
Sea food 3 42.88 
Penicillins 1 14.28 
Tetracycline 1 14.28 
Clindamycin 1 14.28 
Norfloxacin 1 14.28 
Smoking status   
No   388 99.49 
Yes  2 0.51 
Occasional smoking  1 50.00 
Less than 15 cigarettes per day  1 50.00 
15 or more cigarettes per day  0 0 
Number of children    
None    279 71.54 
Having children (median ± IQR = 1.0 ± 0.0;  range = 1 – 
4)  
111 28.46 
Number of consultation topic received* (N = 390)   
1  280 71.79 
2  61 15.64 
3  18 4.62 
4  31 7.95 
Duration of consultation per customer (min.), median ± IQR = 10.00 ± 3.50; range = 5 - 30                                                                
 * A given customer could receive more than one consultation topic.  
    
Effects of using the OCP flowchart for counseling       
Of all 580 OCP use counseling topics provided to 390 
customers, most customers received one topic (71.79%) and 
7.95% received the most number of topics (4 topics). An 
average of 10 minutes per customer was used for counseling 
on the OCP use (Table 2). The most provided topic was 
managing adverse effects of the OCP which accounted for 
180 of 580 topics (31.00%). The most three mentioned effects 
included nausea and vomiting (23.89%), edema (19.45%), 
and oligomenorrhea (11.68%) (Table 3).  
 
 Table 3  The OCP use consultation using the flowchart (390 
patients with 580 topics provided).   
Topic of OCT use consultation  N % 
Managing OCP related adverse effects    
No 400  68.97 
Yes 180 31.03 
Nausea/vomiting  43 23.89 
Edema 35 19.45 
Oligomenorrhea 21 11.68 
Acne  12 6.67 
Dizziness 10 5.56 
Menstrual spotting 10 5.56 
Migraine headache 9 5.00 
Increased appetite 8 4.44 
Weight gain 8 4.44 
Amenorrhea  5 2.78 
Breast engorgement and/or tenderness 4 2.22 
Melasma 3 1.67 
Oily scalp and face 3 1.67 
Excessive vaginal discharge  2 1.11 
Agitation  2 1.11 
Dysmenorrhea or cramp 1 0.55 
Tiredness/fatigue 1 0.55 
Hursuitism 1 0.55 
Hair loss 1 0.55 
Dry skin 1 0.55 
Management of missed doses  143 24.66 
General management for dose missing  106 74.13 
When missing 2 or more doses  22 15.38 
When missing one dose 15 10.49 
How to start OCP (first-time user, re-starter, post-partum)  50 8.62 
Start on the first day of menstruation  39 78.00 
Quick start  11 22.00 
Management of incorrect use of 28-day OCP  46 7.92 
Start the next pack after the end of the menstruation 42 91.30 
Pick the pill corresponding to the labeled date 2 4.34 
Start the next pack on the first day of the menstruation 1 2.18 
Start the next pack after the 7 pill-free days  1 2.18 
Management of missed doses caused by diarrhea and/or 
vomiting  
35 6.03 
How to recognize OCP-related adverse effects  32 5.52 
How to recognize drawbacks of the OCP long-term use 20 3.44 
Less than 5 years  4 20.00 
5 – 10 years 11 55.00 
More than 10 years  5 25.00 
Management of delayed dosing for two days or more  18 3.10 
Management of incorrect use of 21-day OCP  14 2.41 
Start the next pack after the end of the menstruation  13 92.86 
Take the pill continuously without 7 pill-free days  1 7.14 
Management of the new pack with a one-day dosing delay 11 1.90 
Management of switching from other contraceptive method 
(injectable form) to the OCP 
10 1.72 
Referral to the hospital  7 1.20 
Suspected post-menopausal symptoms 3 42.88 
Past positive result of cervical cancer  1 14.28 
Breast exam with lump 1 14.28 
Disrupted supply of hypertensive medications  1 14.28 
Amenorrhea of more than five years 1 14.28 
Management of underlying health problems in relation to the 
OCP  
7 1.20 
Hypertension 5 71.42 
Hyperthyroidism 1 14.29 
Hypertension and arrhythmia 1 14.29 
Management of the OCP with breast enlarging effect 6 1.03 
Management of the contraindicated case of estrogen-containing 
OCP (a case of blood pressure higher than 160/95 mmHg) 
1 0.17 
 
In using the OCP flowchart, eight customers were unable 
to follow the OCP use recommendation. Among these eight 
customers, three experienced adverse effects of the OCP and 
needed a low-estrogen OCP product, i.e. to change from the 
product with 0.03 mg ethinylestradiol and 0.15 mg 
levonorgestrel that caused nausea to a product with a low-
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estrogen content. However, they could not afford such low-
estrogen products which were more costly. Another five 
customers needed more suitable OCP products but the same 
products were preferred. The customers were worried that they 
would lose beneficial effects of the old products. For example, 
the product with lower estrogen was recommended to alleviate 
the edema caused by the product of 0.035 mg ethinylestradiol 
and 2 mg cyproterone. However, the customer preferred to 
continue benefiting the anti-acne and skin nourishing effects 
of the old product.    
   
Opinion of pharmacists toward using the OCP flowchart  
The findings from interviewing 13 pharmacists on five 
issues were as follows. Regarding the general appearance of 
the OCP flowchart, all agreed that texts were presented with 
appropriate fonts’ type and size, and layout. However, seven 
of them reported that the size of the subtopic headline font 
was too small to separate different subtopics apart. Since the 
flowchart contained several pages, the arrows to lead from 
one text box to the other in a given page were functioning 
well; however those connecting between pages were not.  
In terms of content of the OCP flowchart, all pharmacists 
agreed that the content layout and order offered easy reading. 
The text was presented with a concise, appropriate and easily 
understood written language. Most pharmacists (9 of 13) 
reported that the flowchart presented all necessary information 
on the OCP use; while four of them stated that the flowchart 
lacked some crucial detail such as interactions between OCP 
and other medications, selection of the OCP for breast-feeding 
women, and lifestyles that caused dysfunctional uterine 
bleeding. The lack of this information made the pharmacists 
lose the opportunity to use necessary information to manage 
all aspects of the issues found in the customers.  
Regarding the convenience in using the OCP flowchart, 
the majority of pharmacist participants (10 of 13) reported that 
to effectively use the flowchart pharmacists needed be familiar 
with the topics and their order. Otherwise, waste of time and 
loss of the customer’s trust could be a result.   
The issues surrounding the use of OCP flowchart were 
reported by 11 pharmacists as follows. In terms of content 
access, some difficulty in reaching the desired page was 
reported by 9 pharmacists. Four pharmacists reported the 
need of information regarding drug interaction, selection of 
OCP for breast-feeding women, and lifestyle modification in 
case of dysfunctional uterine bleeding. To make a sound 
decision, a comparison of OCP products regarding 
pharmacological effects in relation to the need in specific 
customers was reported necessary.  
 In terms of the usefulness, all pharmacists stated that the 
OCP flowchart helped them update their pharmacology of 
OCP, and aide their history taking, problem identifying, 
selecting appropriate OCP products for specific customers, 
and providing a complete and accurate OCP use advice. With 
these benefits, pharmacists were more confident in providing 
the OCP use counseling which could potentially result in a 
trust among the customers. With the availability of the 
hormone components in each commercial product on the back 
of the OCP flowchart, a few pharmacists reported a faster 
product selection could be achieved. In addition, the most 
useful topic in the OCP flowchart was adjusting hormone 
content to manage adverse effects of the OCP, followed by 
the management when missing doses.  
All pharmacists perceived that the use of OCP flowchart 
could benefit the customers especially on problem identifying 
and solving, and the availability of more complete and 
accurate information of the OCP use. They asserted that the 
future use of OCP flowchart in the drugstores could improve 
the customers’ knowledge of the effective contraception which 
could further alleviate the unwanted pregnancy and unsafe 
abortion. The availability of pharmacists to provide OCP use 
and contraception counseling could add a considerable value 
to the pharmacy service, in addition to the product availability 
service.  
 
Customers’ satisfaction toward the counseling using the 
OCP flowchart  
Of a total score of 5, the average total score of 4.53 points 
was found. The three most approved aspects were the 
intention to use the service in the future (4.63 points), followed 
by the satisfaction on the present recommendation (4.61 
points), and overall satisfaction on the OCP counseling 
service (4.60 points). The least satisfied aspect was history 
taking of the pharmacist (4.41 points) (Table 4).   
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 Table 4   Customer’s satisfaction toward the OCP use 
consultation service using the OCP flowchart (N = 390).  
Satisfaction aspects  Mean ± S.D. 
Satisfaction 
level 
1. Intention to use the service in the future 4.63 ± 0.53 Highest 
2. Satisfaction on the present 
recommendation on the OCP use 
4.61 ± 0.56 Highest 
3. Overall satisfaction on the OCP 
counseling service 
4.60 ± 0.55 Highest 
4. Readiness of the pharmacist in providing 
OCP counseling service 
4.46 ± 0.56 High 
5. Answers provided by the pharmacist 4.45 ± 0.58 High 
6. History taking of the pharmacist  4.41 ± 0.61 High 
Overall 4.53 ± 0.57 Highest 
 
Discussions and Conclusion 
 
In this present study, we tested the OCP flowchart in 
providing care to the customers by 13 community pharmacists. 
As we found a small proportion of the customers with an age 
of 50 years or older (1.79%), they asked for OCP for post-
menopausal symptoms including hot flush, agitation, and 
oligomenorrhea.22 The pharmacists thus recommended a 
referral for a thorough medical examination with the physician.  
Among the recommendation topics provided, about one-
third were adverse effects of the OCP. This suggested that at 
present a large number of OCP users experienced more 
adverse effects than other OCP-related problems. 
Furthermore, almost two-thirds of the clients (62.22%) did not 
recognize that these adverse effects were OCP-related. This 
could be in part because some clients did not pay much 
attention on related information. This finding was consistent 
with the work of Chaimali which found that only 37.55% of 
OCP users made an effort to understand the adverse effects 
information before every use and 37.10% once there was a 
trade-name switching; while 25.35% never learned the 
information.23 On the other hand, pharmacists could also be a 
part of this drawback since they also could provide incomplete 
information. A study of Chalongsuk and colleagues revealed 
that only 11.90% of the clients reported that they received the 
information about OCP adverse effects. However, the 
information regarding OCP use, trade name, and other 
aspects of OCPs was reportedly provided to a greater 
proportion of the clients.5 In accordance with Chalongsuk 
study, Kontiang and co-workers also reported that complete 
information about the OCP adverse effects was provided by 
only 77.08% of the healthcare providers; while other 
information including OCP name and indication was provided 
by a greater proportion of the providers.9  
Among those not accepting the recommendation (2.05%), 
certain factors such as socioeconomic status and social norms 
could have been influential. A study by Muanda and 
colleagues suggested that the access to modern 
contraceptives was detrimentally affected by five factors 
including the fear of adverse effects, cost, influence of the 
social norms, culture and peers, family pressure, and the lack 
of knowledge or the inaccurate information received.  
  
Opinion of pharmacists toward the OCP flowchart  
The OCP flowchart helped pharmacists conduct a more 
thorough history taking and provide an accurate and complete 
consultation. Hence, service at the community pharmacy 
could be more effective. Our findings were consistent with the 
works of Sangkar and Hongsamoot12 and Buanuy14 which 
suggested that for the community pharmacists to provide 
service effectively, specific evidence-based practice protocols 
or guidelines should be readily available and supported by the 
responsible parties. The benefits to the customers were also 
evident. These benefits included the knowledge and practice 
of effective contraception, OCP-related problem identification, 
solving, and prevention. The ultimate benefit of a decrease in 
unplanned pregnancy, unsafe abortion and poor reproductive 
health could be achieved. Studies of Kasiwong and 
colleagues25 and Vogt and Schaefer26 also revealed that the 
OCP educational materials could improve knowledge scores 
significantly. Rodriguez and co-workers found that 
contraceptive services helped teenagers choose a more 
effective contraceptive method.27 Guttmacher Institute in the 
USA reported that contraception consultation service reduced 
the risk of unwanted pregnancy by 2 to 3 folds, unplanned 
delivery by 3 folds, and delivery-related death by half. In 
addition, cost–saving in post-partum care for the mother and 
child was as high as 11.30 thousand million US dollars.28   
 
The customer’s satisfaction toward the consultation using 
the OCP flowchart  
We found that the customers were highly satisfied with the 
OCP use consultation with a mean score of 4.41 of the total 
score of 5 points. This high level of satisfaction could have 
been a result of a comparison with the customer’s past 
experience where consultation service was not available. 
More trust with the pharmacist could be a result. In England, 
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the National Health Service reported that the privacy in the 
OCP use consultation in drugstores was perceived by all 
customers (100.00%). The customers were satisfied the 
consultation and would recommend the service to their peers 
(96.90% and 94.44%, respectively).29  
In terms of limitations, our study was conducted for a 
relatively short period of time, therefore certain OCP related 
problems were not found and the benefits of the OCP 
flowchart to handle such problems could not be examined. 
Studies with a longer period should be conducted to allow for 
more diverse problem coverage. In addition, since our study 
was conducted only in the district of Phasi Charoen, Bangkok, 
the results could be generalized to the other parts of the 
country with some level of caution. Studies with diverse 
populations should be conducted. Furthermore, factors 
potentially influencing the effective use of the OCP flowchart 
should be thoroughly investigated.  
In conclusion, among the 580 OCP-related consultation 
topics provided by the community pharmacists, adverse 
effects were the most provided topic. Pharmacist participants 
reported that complete and accurate identification and 
management of the OCP-related problems could be facilitated 
by using the OCP flowchart. They indicated the need for an 
improvement of the OCP flowchart regarding the layout and 
content. The customers were highly satisfied with the OCP 
use consultation using the OCP flowchart.   
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